NOXOF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Noxopharm (NOXOF) Ownership - Who owns Noxopharm?

Noxopharm Ltd is an Australian clinical-stage drug development company focused on discovering and developing novel treatments for cancer and inflammation, as well as improving mRNA vaccines, based on two preclinical platforms... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

60 Linksley Ave

Phone

N/A

Employees

N/A

Web

https://www.noxopharm.com

Details

Group

Domestic Stock Funds

Fundamentals

NOXOF

Capitalization

12.4M

P/E Ratio

N/A

Risk (Beta)

0.08

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

N/A

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

3.05

Cash Flow

N/A

Earnings

-0.01

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-2.24M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-36.70

Shares Held By Institutions

Shares Outstanding - Current

292M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

0.000

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology